Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
Crossref DOI link: https://doi.org/10.1186/s12933-017-0611-x
Published Online: 2017-10-12
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanaka, Atsushi
Node, Koichi http://orcid.org/0000-0002-2534-0939